Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome

Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving diff...

Full description

Saved in:
Bibliographic Details
Published in:Trends in endocrinology and metabolism 2020-12, Vol.31 (12), p.890-892
Main Authors: Daneshjou, Delbar, Soleimani Mehranjani, Malek, Zadeh Modarres, Shahrzad, Shariatzadeh, Mohammad Ali
Format: Article
Language:English
Subjects:
metformin
polycystic ovarian syndrome
sitagliptin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3
cites cdi_FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3
container_end_page 892
container_issue 12
container_start_page 890
container_title Trends in endocrinology and metabolism
container_volume 31
creator Daneshjou, Delbar
Soleimani Mehranjani, Malek
Zadeh Modarres, Shahrzad
Shariatzadeh, Mohammad Ali
description Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS.
doi_str_mv 10.1016/j.tem.2020.09.002
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2451847654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043276020301752</els_id><sourcerecordid>2451847654</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3</originalsourceid><addsrcrecordid>eNp9kLlOAzEQhi0EIlwPQIO2pNnN2N7LUCHEJU4poba83jFytEewHVDeHqMAJdVM8f2_Zj5CjilkFGg5XWQB-4wBgwxEBsC2yB6tK5FyKOl23CHnKatKmJB97xcANK9psUsmnEMhRMn2yP3MBvXW2WWww_QRgxldb4ez5CJ5ws_kEVurVZfMHarQ4xASOyQvY7fWax-sTp4_lFsns_XQurHHQ7JjVOfx6GcekNfrq_nlbfrwfHN3efGQal7wkGJjTNG0qKtaM8MFZwqh4UwI1TY141Vu6kIb3dJKgWm5ib8W2AjIdY4oGn5ATje9Sze-r9AH2VuvsevUgOPKS5YXtM6rssgjSjeodqP3Do1cOtvHoyUF-e1QLmR0KL8dShAyOoyZk5_6VdNj-5f4lRaB8w2A8ckPi056bXHQUZZDHWQ72n_qvwCJIYKi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2451847654</pqid></control><display><type>article</type><title>Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome</title><source>Elsevier</source><creator>Daneshjou, Delbar ; Soleimani Mehranjani, Malek ; Zadeh Modarres, Shahrzad ; Shariatzadeh, Mohammad Ali</creator><creatorcontrib>Daneshjou, Delbar ; Soleimani Mehranjani, Malek ; Zadeh Modarres, Shahrzad ; Shariatzadeh, Mohammad Ali</creatorcontrib><description>Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS.</description><identifier>ISSN: 1043-2760</identifier><identifier>EISSN: 1879-3061</identifier><identifier>DOI: 10.1016/j.tem.2020.09.002</identifier><identifier>PMID: 33059962</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>metformin ; polycystic ovarian syndrome ; sitagliptin</subject><ispartof>Trends in endocrinology and metabolism, 2020-12, Vol.31 (12), p.890-892</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3</citedby><cites>FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33059962$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daneshjou, Delbar</creatorcontrib><creatorcontrib>Soleimani Mehranjani, Malek</creatorcontrib><creatorcontrib>Zadeh Modarres, Shahrzad</creatorcontrib><creatorcontrib>Shariatzadeh, Mohammad Ali</creatorcontrib><title>Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome</title><title>Trends in endocrinology and metabolism</title><addtitle>Trends Endocrinol Metab</addtitle><description>Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS.</description><subject>metformin</subject><subject>polycystic ovarian syndrome</subject><subject>sitagliptin</subject><issn>1043-2760</issn><issn>1879-3061</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kLlOAzEQhi0EIlwPQIO2pNnN2N7LUCHEJU4poba83jFytEewHVDeHqMAJdVM8f2_Zj5CjilkFGg5XWQB-4wBgwxEBsC2yB6tK5FyKOl23CHnKatKmJB97xcANK9psUsmnEMhRMn2yP3MBvXW2WWww_QRgxldb4ez5CJ5ws_kEVurVZfMHarQ4xASOyQvY7fWax-sTp4_lFsns_XQurHHQ7JjVOfx6GcekNfrq_nlbfrwfHN3efGQal7wkGJjTNG0qKtaM8MFZwqh4UwI1TY141Vu6kIb3dJKgWm5ib8W2AjIdY4oGn5ATje9Sze-r9AH2VuvsevUgOPKS5YXtM6rssgjSjeodqP3Do1cOtvHoyUF-e1QLmR0KL8dShAyOoyZk5_6VdNj-5f4lRaB8w2A8ckPi056bXHQUZZDHWQ72n_qvwCJIYKi</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Daneshjou, Delbar</creator><creator>Soleimani Mehranjani, Malek</creator><creator>Zadeh Modarres, Shahrzad</creator><creator>Shariatzadeh, Mohammad Ali</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202012</creationdate><title>Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome</title><author>Daneshjou, Delbar ; Soleimani Mehranjani, Malek ; Zadeh Modarres, Shahrzad ; Shariatzadeh, Mohammad Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>metformin</topic><topic>polycystic ovarian syndrome</topic><topic>sitagliptin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daneshjou, Delbar</creatorcontrib><creatorcontrib>Soleimani Mehranjani, Malek</creatorcontrib><creatorcontrib>Zadeh Modarres, Shahrzad</creatorcontrib><creatorcontrib>Shariatzadeh, Mohammad Ali</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daneshjou, Delbar</au><au>Soleimani Mehranjani, Malek</au><au>Zadeh Modarres, Shahrzad</au><au>Shariatzadeh, Mohammad Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome</atitle><jtitle>Trends in endocrinology and metabolism</jtitle><addtitle>Trends Endocrinol Metab</addtitle><date>2020-12</date><risdate>2020</risdate><volume>31</volume><issue>12</issue><spage>890</spage><epage>892</epage><pages>890-892</pages><issn>1043-2760</issn><eissn>1879-3061</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effective than either treatment alone in improving different aspects of PCOS.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>33059962</pmid><doi>10.1016/j.tem.2020.09.002</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-2760
ispartof Trends in endocrinology and metabolism, 2020-12, Vol.31 (12), p.890-892
issn 1043-2760
1879-3061
language eng
recordid cdi_proquest_miscellaneous_2451847654
source Elsevier
subjects metformin
polycystic ovarian syndrome
sitagliptin
title Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T15%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sitagliptin/Metformin:%20A%20New%20Medical%20Treatment%20in%20Polycystic%20Ovary%20Syndrome&rft.jtitle=Trends%20in%20endocrinology%20and%20metabolism&rft.au=Daneshjou,%20Delbar&rft.date=2020-12&rft.volume=31&rft.issue=12&rft.spage=890&rft.epage=892&rft.pages=890-892&rft.issn=1043-2760&rft.eissn=1879-3061&rft_id=info:doi/10.1016/j.tem.2020.09.002&rft_dat=%3Cproquest_cross%3E2451847654%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-ebff5bdec78c2f3932ae0b3299adb82374f85cfcd17a0fd3f1015eb904c4ee9b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2451847654&rft_id=info:pmid/33059962&rfr_iscdi=true